Encapsulation of the antimicrobial and immunomodulator agent nitazoxanide within polymeric micelles

Journal of Nanoscience and Nanotechnology

Volumn 14, Issue 6, 2014, Pages 4670-4682

  Glisoni, Romina J ^a,b   Sosnik, Alejandro ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Lactosylated nanocarriers; Nitazoxanide; Polymeric micelles; Viral hepatitis

Indexed keywords

AMPHIPHILES; ANTIMICROBIAL AGENTS; HYDROPHILICITY; HYDROPHOBICITY; MICELLES; NONIONIC SURFACTANTS; POLYETHYLENE OXIDES; POLYMERS; PROPYLENE; SOLUBILITY; VIRUSES;

ANTI-MICROBIAL ACTIVITY; ENCAPSULATION CAPACITY; HEPATOCELLULAR CARCINOMA; HYDROPHILIC-LIPOPHILIC BALANCE; NANO-CARRIERS; NITAZOXANIDE; POLYMERIC MICELLE; VIRAL HEPATITIS;

ENCAPSULATION;

ANTIINFECTIVE AGENT; IMMUNOLOGIC FACTOR; NANOCAPSULE; NITAZOXANIDE; POLYMER; THIAZOLE DERIVATIVE;

ARTICLE; CHEMISTRY; CONFORMATION; CRYSTALLIZATION; DIFFUSION; MATERIALS TESTING; METHODOLOGY; MICELLE; PARTICLE SIZE; SURFACE PROPERTY; ULTRASTRUCTURE;

ANTI-INFECTIVE AGENTS; CRYSTALLIZATION; DIFFUSION; IMMUNOLOGIC FACTORS; MATERIALS TESTING; MICELLES; MOLECULAR CONFORMATION; NANOCAPSULES; PARTICLE SIZE; POLYMERS; SURFACE PROPERTIES; THIAZOLES;

EID: 84899735901     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2014.8647     Document Type: Article

References (55)

1. L. G. Guidotti and F. V. Chisari, Annu. Rev. Patol. Mech. Dis. 1, 23 (2006).
2. T. Block, A. S. Mehta and W. T. London, Cancer Biomark. 9, 375 (2011).
3. P. P. Michielsen, S. M. Francque, and J. L. van Dongen, World J. Surg. Oncol. 3, 27 (2005).
4. S. F. Altekruse, K. A. McGlynn, and M. E. Reichman, J. Clin. Oncol. 27, 1485 (2009).
5. Cancer. World Health Organization. (2012), http://www.who.int/ mediacentre/factsheets/fs297/en/
6. M. L. Cuestas, V. L. Mathet, J. R. Oubina, and A. Sosnik, Pharm. Res. 27, 1184 (2010).
7. R. J. Glisoni, D. A. Chiappetta, L. M. Finkielstein, A. G. Moglioni, and A. Sosnik, New J. Chem. 34, 2047 (2010).
8. R. J. Glisoni, D. A. Chiappetta, A. G. Moglioni and A. Sosnik, Pharm. Res. 29, 739 (2012).
9. R. J. Glisoni, M. L. Cuestas, V. Mathet, J. Oubina, A. G. Moglioni, and A. Sosnik, Eur. J. Pharm. Sci. 47, 596 (2012).
10. V. R. Anderson and M. P. Curran, Drugs 67, 1947 (2007).
11. J. O. Juan, N. Lopez Chegne N, G. Gargala, and L. Favennec, Transact. Royal Soc. Tropical Med. Hyg. 96, 196 (2002).
12. L. M. Fox and L. D. Saravolatz, Clin. Infect. Dis. 40, 1173 (2005).
13. E. Diaz, J. Mondragon, E. Ramirez, and R. Bernai, Am. J. Tropical Med. Hyg. 68, 384 (2003).
14. L. Favennec, J. J. Ortiz, G. Gargala, N. Lopez Chegne, A. Ayoub, and J. F Rossignol, Aliment. Pharmacol. Ther 17, 265 (2003).
15. D. M. Musher, N. Logan, R. J. Hamill, H. L. DuPont, A. Lentnek, A. Gupta, and J.-F Rossignol, Clin. Infect. Dis. 43, 421 (2006).
16. L. P. De Carvalho, C. M. Darby, K. Y. Rhee, and C. Natahan, ACS Med. Chem. Lett. 2, 849 (2011).
17. J. B. Watson and S. F Moss, Am. J. Gastroenterol. 106, 1976 (2011).
18. J. F Rossignol and Y. M. El-Gohary, Aliment. Pharmacol. Ther. 24, 1423 (2006).
19. J. F Rossignol, M. Abu-Zekry, A. Hussein, and M. G. Santoro, Lancet 368, 124 (2006).
20. B. E. Korba, A. B. Montera, K. Farrar, K. Gaye, S. Mukeriee, M. S. Ayers, and J. F Rossignol, Antiviral Res. 77, 56 (2008).
21. E. B. Keffee and J. F. Rossignol, World J. Gastroenterol. 15, 1805 (2009).
22. A. V. Stachulski, C. Pidathala, E. C. Row, R. Sharma, N. G. Berry, A. S. Lawrenson, S. L. Moores, M. Iqbal, J. Bentley, S. A. Allman, G. Edwards, A. Helm, J. Hellier, B. E. Korba, J. E. Semple, and J. F. Rossignol, J. Med. Chem. 54, 8670 (2011).
23. I. Mederacke and H. Wedemeyer, Ann. Hepatol. 8, 166 (2009).
24. W. Z. Kolozsi, Y. El. Gohary, E. B. Keeffe, and J. F. Rossignol, Am. J. Gastroenterol. 103, S150 (2008).
25. M. Elazar, M. Liu, S. McKenna, P. Liu, E. A. Gehrig, A. Eifert, J. Puglisi, J. F. Rossignol, and J. S. Glenn, Hepatol. 48, 1151A (2008).
26. M. Clerici, D. Trabattoni, M. Pacei, M. Biasin, and J. F. Rossignol, J. Immunol. 186, 155 (2011).
27. J. R. Murphy and J. C. Friedmann, J. Appl. Toxicol. 5, 49 (1985).
28. K. Kataoka, A. Harada, and Y. Nagasaki, Adv. Drug Del. Rev. 47, 113 (2001).
29. S. R. Croy and G. S. Kwon, Curr. Pharm. Design 12, 4669 (2006).
30. A. Sosnik, A. Carcaboso, and D. A. Chiappetta, Recent Pat. Biomed. Eng. 1, 43 (2008).
31. D. A. Chiappetta and A. Sosnik, Eur J. Pharm. Biopharm. 66, 303 (2007).
32. A. Sosnik, Temperature- and pH-sensitive polymeric micelles for drug encapsulation, release and targeting, Smart Materials for Drug Delivery, edited by C. Alvarez-Lorenzo and A. Concheiro, Royal Society of Chemistry, London (2013), p. 115.
33. J. Gonzalez-Lopez, C. Alvarez-Lorenzo, P. Taboada, A. Sosnik, I. Sandez-Macho, and A. Concheiro, Langmuir 24, 10688 (2008).
34. D. A. Chiappetta, J. Degrossi, S. Teves, M. D'Aquino, C. Bregni, and A. Sosnik, Eur J. Pharm. Biopharm. 69, 535 (2008).
35. D. A. Chiappetta, C. Hocht, C. Taira, and A. Sosnik, Nanomedicine (Lond). 5, 11(2010).
36. D. A. Chiappetta, C. Hocht, C. Taira, and A. Sosnik, Biomaterials 32, 2379 (2011).
37. R. N. Peroni, S. S. Di Gennaro, C. Hocht, D. A. Chiappetta, M. C. Rubio, A. Sosnik, and G. F. Bramuglia, Biochem. Pharmacol. 82, 1227 (2011).
38. A. Ribeiro, A. Sosnik, D. A. Chiappetta, F. Veiga, A. Concheiro, and C. Alvarez-Lorenzo, J. Royal Soc.-Interface 9, 2059 (2012).
39. D. A. Chiappetta, C. Hocht, J. A. W. Opezzo, and A. Sosnik, Nanomedicine (Lond.) 8, 223 (2013).
40. M. L. Cuestas, A. Castillo, A. Sosnik, and V. L. Mathet, Bioorg. Med. Chem. Lett. 22, 6577 (2012).
41. C. Alvarez-Lorenzo, A. Rey-Rico, J. Brea, M. I. Loza, A. Concheiro, and A. Sosnik, Nanomedicine (Lond.) 5, 1371 (2010).
42. M. L. Cuestas, A. Sosnik, and V. L. Mathet, Mol. Pharmaceutics 8, 1152(2011).
43. A. Sosnik, Adv. Drug Del. Rev. (2004), submitted.
44. C. Eisenburg, N. Seta, M. Appel, G. Feldmann, G. Durand, and J. J. Feger, Hepatol. 13, 305 (1991).
45. L. Fiume, C. Busi, G. Di Stefano, and A. Mattioli, Adv. Drug Del. Rev. 14, 51 (1994).
46. Y. Li, G. Huang, J. Diakur, and LI. Wiebe, Curr. Drug Deliv. 5, 299 (2008).
47. R. Kikker, B. Lepenies, A. Dibekian, P. Laurino, and P. H. Seeberger, J. Am. Chem. Soc. 131, 2110 (2009).
48. J. Zhang, C. Li, Xue-ZY, H. W. Cheng, F. W. Huang, R. X. Zhuo, and X. Z. Zhang, Acta Biomater 7, 1655 (2011).
49. M. L. Cuestas, R. J. Glisoni, V. L. Mathet, and A. Sosnik, J. Nanopart. Res. 15, Art. 1389 (2013).
50. F P. Bruno, M. R. Caira, G. A. Monti, D. E. Kassuha, and N. R. Sperandeo, J. Mol. Struct. 984, 51 (2010).
51. D. A. Chiappetta, G. Facorro, E. Rubin de Celis, and A. Sosnik, Nanomedicine: NBM 7, 624 (2011).
52. J. Dong, B. Z. Chowdhry, and S. A. Leharne, Colloids Surf. A: Physicochemical and Engineering Aspects 212, 9 (2003).
53. A. V. Kabanov, I. R. Nazarova, I. V. Astafieva, E. V. Batrakova, V. Y Alakhov, A. A. Yaroslavov, and V. A. Kabanov, Macromolecules 28, 2303 (1995).
54. L. Wan, X. Zhang, S. Pooyan, M. S. Palombo, M. J. Leibowitz, S. Stein, and P. J. Sinko, Bioconj. Chem. 19, 28 (2008).
55. D. A. Chiappetta, J. Degrossi, R. A. Lizarazo, D. L. Salinas, F Martinez, A. Sosnik, L. Segewicz, and M. Petrowsky (eds.), Nova Publishers, Hauppauge, NY (2011), p. 197.